Join Now

CIPROMS Revenue and Competitors

Claim your profile

Indianapolis, IN USA

Location

N/A

Total Funding

Hospital/Healthcare

Industry

Estimated Revenue & Valuation

  • CIPROMS's estimated annual revenue is currently $21.1M per year.(i)
  • CIPROMS's estimated revenue per employee is $208,515

Employee Data

  • CIPROMS has 101 Employees.(i)
  • CIPROMS grew their employee count by -1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M6710%N/AN/A
#2
$25.1M939%N/AN/A
#3
$9.5M57850%N/AN/A
#4
$6.5M398%N/AN/A
#5
$7.3M442%N/AN/A
#6
$80.2M2703%N/AN/A
#7
$10.8M6530%N/AN/A
#8
$738.2M195314%N/AN/A
#9
$21.9M104-29%N/AN/A
#10
$8.6M40122%N/AN/A

Experience. Integrity. Advocacy. In CIPROMS, you’ll find a proven system to strengthen your practice and enhance patient satisfaction. The CIPROMS advantage includes personalized service, timely and reliable information, with transparent and trusted accountability. We’re here to do our job, so you can focus on yours. CIPROMS specializes in customized medical billing for hospital-based groups including anesthesiologists, emergency physicians, and hospitalists, as well as ASCs and office-based practices. We offer full-service or stand-alone options, including provider enrollment, certified medical coding, and consulting. CIPROMS provides services designed to increase your revenue, improve cash flow, reduce costs, and minimize the administrative aggravations associated with ever-changing rules and regulations. Plus, our services can be customized to fit the needs of our clients. Contact us today to take the next step in reducing your administrative burden and increasing your revenue. We would be happy to talk with you about the many options for CIPROMS to be your medical billing partner.

keywords:N/A

N/A

Total Funding

101

Number of Employees

$21.1M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M101-1%N/A
#2
$22.2M1016%N/A
#3
$15.2M10125%N/A
#4
$15M10120%N/A
#5
$3.5M101-5%N/A